Clinical trial
An Exploratory Study of Metformin With or Without Rapamycin as Maintenance Therapy After Induction Chemotherapy in Subjects With Metastatic Pancreatic Adenocarcinoma
NCT02048384 is registered in ClinicalTrials.gov with Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Exploratory Study of Metformin With or Without Rapamycin as Maintenance Therapy After Induction Chemotherapy in Subjects With Metastatic Pancreatic Adenocarcinoma
- Lead sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- June 10, 2014
- Completion date
- September 30, 2019
- Enrollment
- 22 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
metastatic pancreatic adenocarcinoma